Related Articles
A phase II study of a personalized peptide vaccination for chemotherapy-resistant advanced pancreatic cancer patients
Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimens
Personalized peptide vaccination for advanced biliary tract cancer: IL-6, nutritional status and pre-existing antigen-specific immunity as possible biomarkers for patient prognosis
Immune responses of patients without cancer recurrence after a cancer vaccine over a long term
Combined treatment of dendritoma vaccine and low-dose interleukin-2 in stage IV renal cell carcinoma patients induced clinical response: A pilot study